Bassi, Pierfrancesco
 Distribuzione geografica
Continente #
EU - Europa 24.271
NA - Nord America 12.940
AS - Asia 7.596
SA - Sud America 1.389
Continente sconosciuto - Info sul continente non disponibili 434
AF - Africa 233
OC - Oceania 35
AN - Antartide 2
Totale 46.900
Nazione #
IT - Italia 15.096
US - Stati Uniti d'America 12.554
SG - Singapore 3.516
DE - Germania 2.790
CN - Cina 1.695
SE - Svezia 1.506
BR - Brasile 1.093
FR - Francia 1.029
NL - Olanda 932
UA - Ucraina 758
VN - Vietnam 626
GB - Regno Unito 508
IN - India 412
IE - Irlanda 360
PL - Polonia 343
ID - Indonesia 241
BD - Bangladesh 210
CA - Canada 210
FI - Finlandia 208
RU - Federazione Russa 197
JP - Giappone 172
HK - Hong Kong 150
AR - Argentina 113
TR - Turchia 109
CH - Svizzera 104
BE - Belgio 94
ES - Italia 87
MX - Messico 74
IQ - Iraq 71
ZA - Sudafrica 58
PK - Pakistan 47
EC - Ecuador 46
CI - Costa d'Avorio 41
MA - Marocco 37
AT - Austria 36
CO - Colombia 36
KR - Corea 36
VE - Venezuela 30
RO - Romania 28
IR - Iran 27
JO - Giordania 27
AL - Albania 26
PH - Filippine 26
AU - Australia 25
AZ - Azerbaigian 24
LT - Lituania 24
SA - Arabia Saudita 24
UZ - Uzbekistan 22
EG - Egitto 21
MY - Malesia 21
AE - Emirati Arabi Uniti 20
CL - Cile 20
CR - Costa Rica 16
HU - Ungheria 16
NP - Nepal 16
PY - Paraguay 16
TN - Tunisia 15
CZ - Repubblica Ceca 14
GR - Grecia 13
IL - Israele 13
PE - Perù 13
PT - Portogallo 13
BZ - Belize 12
EU - Europa 12
PA - Panama 12
TH - Thailandia 12
TW - Taiwan 12
DO - Repubblica Dominicana 11
KE - Kenya 11
TT - Trinidad e Tobago 11
UY - Uruguay 11
BO - Bolivia 10
RS - Serbia 10
DZ - Algeria 9
JM - Giamaica 9
NG - Nigeria 9
LB - Libano 8
LK - Sri Lanka 8
SN - Senegal 8
BG - Bulgaria 7
BH - Bahrain 7
ET - Etiopia 7
LV - Lettonia 7
BY - Bielorussia 6
DK - Danimarca 6
HN - Honduras 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
OM - Oman 6
SK - Slovacchia (Repubblica Slovacca) 6
A2 - ???statistics.table.value.countryCode.A2??? 5
HR - Croazia 5
IS - Islanda 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LU - Lussemburgo 5
MD - Moldavia 5
NI - Nicaragua 5
SM - San Marino 5
BB - Barbados 4
Totale 46.399
Città #
Singapore 1.905
Chandler 1.631
Milan 1.463
Ashburn 1.354
Rome 1.326
San Jose 1.076
Jacksonville 430
Naples 427
Beijing 361
Los Angeles 348
Dublin 347
San Mateo 333
Ann Arbor 318
Florence 277
New York 268
Turin 254
Wilmington 250
Nanjing 242
Ho Chi Minh City 221
Jakarta 218
Warsaw 215
Bologna 208
Lauterbourg 202
Palermo 183
Bari 180
Houston 166
Munich 165
Hanoi 157
The Dalles 155
Dearborn 153
Frankfurt am Main 152
Woodbridge 146
Catania 140
Boston 136
Hong Kong 131
Bremen 130
Nanchang 128
Genoa 126
Nürnberg 125
Dallas 124
São Paulo 123
Verona 123
Chicago 117
Lawrence 115
Tokyo 113
Fairfield 108
Hefei 104
Moscow 98
Marseille 91
Cattolica 90
Redwood City 87
Seattle 87
Kraków 83
Buffalo 82
Santa Clara 81
Princeton 79
Brussels 76
Brescia 73
Atlanta 70
Padova 66
Lancaster 59
Helsinki 58
Cagliari 56
Venice 56
Mountain View 55
Toronto 55
Paris 53
Ottawa 52
Parma 52
Falls Church 51
Amsterdam 50
Council Bluffs 49
London 49
Orem 48
Taranto 48
Reggio Emilia 47
Kunming 45
Izmir 44
Montreal 44
Hyderabad 43
Pescara 43
Boardman 42
Perugia 42
Redmond 42
Abidjan 41
Bergamo 41
Messina 41
Tianjin 41
Brooklyn 40
Salerno 36
Cambridge 35
Livorno 35
Phoenix 35
San Francisco 35
Belo Horizonte 34
Stockholm 34
University Park 34
Hebei 33
Johannesburg 33
Augusta 32
Totale 19.800
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 12.272
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.245
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 997
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 927
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 619
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 440
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 436
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 423
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 361
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 328
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 328
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 320
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 300
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making 288
Pros-IT CNR: an Italian prostate cancer monitoring project 285
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 278
Metabolic reprogramming by malat1 depletion in prostate cancer 272
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 270
Le infezioni delle vie urinarie 259
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 256
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 255
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 242
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 234
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 218
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 211
Urological complications following inguinal hernioplasty 205
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 204
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 202
The occult urothelial cancer 201
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 194
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 192
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 190
Le complicanze nella chirurgia urologica 189
Evidenze microbiologiche in un singolo centro urologico 188
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 188
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 185
Male infertility: non-surgical therapy 183
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 182
[Foreign bodies in urinary bladder: a clinical case] 179
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 177
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 176
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 176
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 176
Human factors in surgery: from Three Mile Island to the operating room 175
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 174
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 173
Size of Bladder Cancers: Correlation among Different Types of Measurement 172
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 172
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 172
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 172
[Overactive bladder syndrome: the social and economic perspective] 171
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 170
Extracorporeal shockwave lithotripsy in pediatrics 169
Imaging in prostate cancer diagnosis: present role and future perspectives 169
Hot topics in urological health economics. A mini review 169
Therapeutic strategies in penile cancer: state of the art 169
Bladder and prostate metastasis from small cell lung cancer: a rare entity 169
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 168
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 167
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 166
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 165
Antibiotic prophylaxis in urology 164
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 164
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 164
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 163
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 163
Advanced bladder cancer: New agents and new approaches. A review 160
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 160
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 160
Microbiological follow-up of nosocomial infections in a single urological center 160
Brachytherapy in men with prostate cancer: update on indications and outcomes 159
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 158
Imaging of renal cell carcinoma: state of the art and recent advances 157
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 156
Imaging in prostate cancer staging: present role e future perspectives 156
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 156
NBI: results review 156
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 154
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 154
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 154
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 153
[Innovative treatments of non muscle invasive bladder cancer] 152
Chirurgia robotica per tutti 152
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 152
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 150
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 150
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 150
Test F+10 SP: un nuovo metodo angioscintigrafico per la diagnosi dell'uropatia ostruttiva 149
Advanced bladder cancer: New agents and new approaches. A review 149
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 147
Imaging in prostate cancer staging: present role and future perspectives 146
Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy 146
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 145
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 145
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 144
Circumcision: history, religion and law 144
Local relapse of prostate cancer after primary definitive treatment: the management 144
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 143
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 143
Totale 34.528
Categoria #
all - tutte 141.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.058 0 147 77 182 186 112 79 297 138 161 304 375
2022/20235.995 686 637 419 779 341 641 270 479 639 280 480 344
2023/20246.891 384 811 433 550 478 598 528 628 449 613 641 778
2024/20259.615 640 753 881 716 953 638 643 723 1.104 746 994 824
2025/202611.696 1.722 482 702 1.115 1.886 654 2.072 645 753 821 499 345
2026/20271.758 523 1.235 0 0 0 0 0 0 0 0 0 0
Totale 46.900